Durvalumab / Tremelimumab Combination Therapy clinical trials

Durvalumab and Tremelimumab for Pediatric Malignancies

This study is testing new drug combinations to treat children and teenagers with advanced cancer. We're looking for the safest and most effective dose of these immunotherapy drugs, durvalumab and tremelimumab, for solid and blood cancers.